These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 15386562)

  • 21. Molecular analysis of the CDR3 encoding region of the immunoglobulin heavy chain locus in cerebrospinal fluid cells as a diagnostic tool in lymphomatous meningitis.
    Storch-Hagenlocher B; Haas J; Vogt-Schaden ME; Bentz M; Hoffmann LA; Biessmann A; Wildemann B
    Ann Neurol; 2000 Feb; 47(2):211-7. PubMed ID: 10665492
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Detection of minimal disease in hematopoietic malignancies of the B-cell lineage by using third-complementarity-determining region (CDR-III)-specific probes.
    Yamada M; Hudson S; Tournay O; Bittenbender S; Shane SS; Lange B; Tsujimoto Y; Caton AJ; Rovera G
    Proc Natl Acad Sci U S A; 1989 Jul; 86(13):5123-7. PubMed ID: 2500663
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The incidence of T-cell receptor gene rearrangements in childhood B-lineage acute lymphoblastic leukemia is related to immunophenotype and fusion oncogene expression.
    Meleshko AN; Belevtsev MV; Savitskaja TV; Potapnev MP
    Leuk Res; 2006 Jul; 30(7):795-800. PubMed ID: 16386788
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Detection of minimal residual disease in B lineage acute lymphoblastic leukemia by 4-color flow cytometry].
    Liu YR; Wang H; Chang Y; Cheng YF; Fu JY; Zhang LP; Liu GL; Chen SS
    Zhonghua Xue Ye Xue Za Zhi; 2005 Jun; 26(6):327-31. PubMed ID: 16185473
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Detection of minimal residual disease in childhood B-ALL by flow cytometry].
    Xu C; Zhao HJ; Wu ZH; Xue HL; Tang JY; Chen J; Pan C; Chen J; Li L; Gu LJ; Shen LS
    Zhonghua Xue Ye Xue Za Zhi; 2003 Jun; 24(6):295-9. PubMed ID: 12859864
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Epitopes recognized by cytotoxic T lymphocytes in immunoglobulin heavy chain variable regions expressed by B-cell acute lymphoblastic leukemia].
    Liu Y; Zhu P; Hu YM
    Zhonghua Zhong Liu Za Zhi; 2005 Feb; 27(2):106-10. PubMed ID: 15946551
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The bcl-2/IgH rearrangement in a population of 204 healthy individuals: occurrence, age and gender distribution, breakpoints, and detection method validity.
    Schmitt C; Balogh B; Grundt A; Buchholtz C; Leo A; Benner A; Hensel M; Ho AD; Leo E
    Leuk Res; 2006 Jun; 30(6):745-50. PubMed ID: 16297448
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Preliminary results of the use of MRD test among children with acute lymphoblastic leukaemia].
    Raciborska A; Wypych A; Rokicka-Milewska R; Siedlecki JA; Kulik J
    Przegl Lek; 2004; 61 Suppl 2():62-6. PubMed ID: 15686049
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Novel three-break rearrangement and cryptic translocations leading to colocalization of MYC and IGH signals in B-cell acute lymphoblastic leukemia.
    Tchinda J; Volpert S; Berdel WE; Büchner T; Horst J
    Cancer Genet Cytogenet; 2006 Mar; 165(2):180-4. PubMed ID: 16527615
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Detectable minimal residual disease before allogeneic hematopoietic stem cell transplantation predicts extremely poor prognosis in children with acute lymphoblastic leukemia.
    Sramkova L; Muzikova K; Fronkova E; Krejci O; Sedlacek P; Formankova R; Mejstrikova E; Stary J; Trka J
    Pediatr Blood Cancer; 2007 Jan; 48(1):93-100. PubMed ID: 16521130
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Chemiluminescent detection of gene rearrangements in hematologic malignancy.
    Hodges KA; Kosciol CM; Rezuke WN; Abernathy EC; Pastuszak WT; Tsongalis GJ
    Ann Clin Lab Sci; 1996; 26(2):114-8. PubMed ID: 8852419
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Plasma-based detection of clonality in lymphoid malignancies.
    Yeh CH; Tseng R; Albitar M
    Eur J Haematol; 2009 Jun; 82(6):450-3. PubMed ID: 19187275
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Bone marrow minimal disseminated disease (MDD) and minimal residual disease (MRD) in childhood T-cell lymphoblastic lymphoma stage III, detected by flow cytometry (FC) and real-time quantitative polymerase chain reaction (RQ-PCR).
    Stark B; Avigad S; Luria D; Manor S; Reshef-Ronen T; Avrahami G; Yaniv I
    Pediatr Blood Cancer; 2009 Jan; 52(1):20-5. PubMed ID: 19006253
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The use of IgH fingerprinting and ASO-dependent PCR for the investigation of residual disease (MRD) in ALL.
    Chim JC; Coyle LA; Yaxley JC; Cole-Sinclair MF; Cannell PK; Hoffbrand VA; Foroni L
    Br J Haematol; 1996 Jan; 92(1):104-15. PubMed ID: 8562380
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Quantification of free total plasma DNA and minimal residual disease detection in the plasma of children with acute lymphoblastic leukemia.
    Schwarz AK; Stanulla M; Cario G; Flohr T; Sutton R; Möricke A; Anker P; Stroun M; Welte K; Bartram CR; Schrappe M; Schrauder A
    Ann Hematol; 2009 Sep; 88(9):897-905. PubMed ID: 19165483
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Molecular characterization of Waldenstrom's macroglobulinemia reveals frequent occurrence of two B-cell clones having distinct IgH VDJ sequences.
    Kriangkum J; Taylor BJ; Treon SP; Mant MJ; Reiman T; Belch AR; Pilarski LM
    Clin Cancer Res; 2007 Apr; 13(7):2005-13. PubMed ID: 17404080
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Multiparametric flow cytometry in detection of minimal residual disease in acute lymphoblastic leukemia of early B-cell phenotype.
    Mlcáková A; Babusíková O
    Neoplasma; 2003; 50(6):416-21. PubMed ID: 14689062
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Tandem application of flow cytometry and polymerase chain reaction for choice targets of minimal residual disease in childhood acute lymphoblastic leukemia].
    Tie LJ; Gu LJ; Jiang LM; Zhao JC; Chen J; Pan C; Dong L; Chen J; Xue HL; Tang JY; Wang YP
    Zhongguo Dang Dai Er Ke Za Zhi; 2009 Apr; 11(4):246-50. PubMed ID: 19374803
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Unusual sequence of VDJ rearrangement revealed by molecular analysis in a patient with indolent lymphoma.
    Cerny J; Slavickova A; Krepelova A; Trneny M; Karban J; Klener P
    Haematologica; 2003 May; 88(5):ECR15. PubMed ID: 12745284
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Presentation of a PCR-nuclease protection strategy for minimal residual disease monitoring in B-ALL.
    Limón A; Bertran J; Llucià M; Carmona M; Canals C; Ortega JJ; García J; Rueda F
    Leukemia; 1995 Apr; 9(4):656-61. PubMed ID: 7723401
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.